Barreto et al. also demonstrated that soluble biglycan is commonly detected in knee synovial fluid of patients with advanced knee OA or rheumatoid arthritis (RA) (Barreto et al., 2015). This evidence concerns the gene BGN and rheumatoid arthritis.